Pacer Advisors, Inc. Voyager Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.42 - $10.54 $341 - $484	-46 Reduced 8.3%	508 $4,000
Q1 2024 May 10, 2024	BUY	$7.15 - $10.84 $3,961 - $6,005	554 New	554 $5,000
Q4 2020 Jan 20, 2021	SELL	$7.15 - $12.28 $11,011 - $18,911	-1,540 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$10.01 - $13.75 $15,415 - $21,175	1,540 New	1,540 $16,000
Q4 2018 Feb 13, 2019	SELL	$8.59 - $18.05 $28,106 - $59,059	-3,272 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $55,983 - $71,133	3,272 New	3,272 $62,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.